AIFinancial Timesabout 2 hours ago
Takeda, Insilico Strike $600M AI Drug Deal
1 min read
Insilico Medicine partnered with Takeda in a deal valued at up to $600 million for AI-driven drug discovery. The collaboration aims to leverage Insilico's artificial intelligence platform to identify and develop new drug candidates for Takeda's pipeline.
Level
Hype check
Tap to vote and see what everyone thinks.
